Laurus Labs Limited (LAURUSLABS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Laurus Labs Limited (NSE: LAURUSLABS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹1,954.00, market capitalisation ₹1,05,577 Cr, P/E 96.6, ROE 18.3%.
Get the AI verdict on LAURUSLABS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
LAURUSLABS price and valuation
- Share price
- ₹1,954.00
- Market cap
- ₹1,05,577 Cr
- P/E ratio
- 96.6
- P/B ratio
- 19.9
- EPS
- ₹20.24
- Book value per share
- ₹98.20
- Dividend yield
- 0.1%
LAURUSLABS profitability and growth
- ROE
- 18.3%
- ROCE
- 17.8%
- Debt to equity
- 0.46
- Revenue growth (3 yr)
- 4%
- Revenue growth (5 yr)
- 7%
- Profit growth (3 yr)
- 4%
- Profit growth (5 yr)
- -2%
LAURUSLABS 52-week range
- 52-week high
- ₹1,982.00
- 52-week low
- ₹823.10
- Face value
- ₹2.00
LAURUSLABS shareholding pattern
- Promoters
- 27.47%
- FIIs
- 28%
- DIIs
- 13.73%
- Public
- 30.79%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.